The discovery of rapamycin in 1972 did not create major waves in the oncology community. But in 1989, Michael N. Hall, Ph.D., took a second look, screening yeast cells for rapamycin resistance. That led to the discovery of TOR, or “Target of Rapamycin,” and one of the most profound paradigm…...
Medical Coalition Led Largely by NFCR Unites to Battle Glioblastoma
Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is the first platform trial for…...
Bringing International Partners Together
(clockwise) NFCR President Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin In recent months, the National Foundation for Cancer Research (NFCR) has signed memorandums of understanding with two major foreign institutions, the China Pharmaceutical Innovation and Research Development Association (PhIRDA) and the Australia-based…...
NFCR at the 2018 American Association for Cancer Research Annual Meeting
The National Foundation for Cancer Research’s (NFCR) presence is considerable at the 109th annual meeting of the American Association for Cancer Research (AACR), which kicks off tomorrow in Chicago and runs through the following four days. One of the most widely anticipated regular gatherings of cancer scientists in the United…...
New Test Developed for Pre-Cancerous Barrett’s Esophagus
In recognition of Esophageal Cancer Awareness Month, this National Foundation for Cancer Research post offers a look at a significant diagnostic advancement for a risk factor associated with the terrible disease. A new test for Barrett’s esophagus, a precancerous forerunner of the much deadlier esophageal adenocarcinoma, is in clinical trials…...
Head, Neck and Mouth Cancer Prevention through Awareness and Understanding
Cancer can often feel like a disease of mysterious origin. There are difficult to pronounce words, complex statistics and evolving theories involved in the explanation of the development of cancer. Its nefariousness and criticality can create a fear-associated mental distancing or even an attitude of fatalism. Together, this can allow…...
Two National Foundation for Cancer Research Scientists Among the National Academy of Inventors’ Latest Class
FOR IMMEDIATE RELEASE: April 5, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Honor Recognizes Top Academic Inventors BETHESDA, MD – In an event this afternoon at the historic Mayflower Hotel in Washington, DC, two funded scientists of the National Foundation…...
Strategic Media Partner
